Ethics approval and consent to participate
All tests were performed under a NYBC IRB approved protocol. Convalescent donor plasma was collected by the New York Blood Center (NYBC) with written consent from patients in accordance with NYBC Institutional Review Board protocols.
Consent for publication
All authors agree to submit for consideration for publication in the journal.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding authors on reasonable request.
CL worked with the LFD manufacturer on the Emergency Use Authorization submission to the US FDA.
The LFD used in the testing were provided by CL/BioSolutions services LLC.
LL and CDH conceived this study. CL provided financial and administrative support. BR and DJ performed most of the data analysis and collected the data using the CP cohort. CL provided the devices for this study. All authors discussed the results, explained them further and prepared the tables and panels for these figures. CL, LL, CDH, BS and BR wrote the manuscript. All authors read and approved the final manuscript.
We would like to thanks Ryan Dagenais for his editorial support with the manuscript; Ryan’s services were funded by BioSolutions Services LLC.
1New York Blood Center Lindsley F. Kimball Research Institute, New York, NY 10065 USA
2 BioSolutions Services, Englewood Cliffs, New Jersey, United States; Department of Management and Entrepreneurship, Silberman College of Business, Fairleigh Dickinson University, Teaneck, New Jersey, United States; Weatherhead School of Management, Case Western Reserve University, Cleveland, Ohio, USA